ADMA Biologics (ADMA)
(Delayed Data from NSDQ)
$6.81 USD
+0.07 (1.04%)
Updated May 3, 2024 04:00 PM ET
After-Market: $6.80 -0.01 (-0.15%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: AMC |
3/2024 | $0.05 | 0.00% |
Earnings Summary
For their last quarter, ADMA Biologics (ADMA) reported earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This reflects a positive earnings surprise of 100.00%. Look out for ADMA's next earnings release on May 09, 2024. For the next earning release, we expect the company to report earnings of $0.05 per share, reflecting a year-over-year increase of 266.67%.
Earnings History
Price & Consensus
Zacks News for ADMA
Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True?
ADMA: What are Zacks experts saying now?
Zacks Private Portfolio Services